Peptide Samples
Peptide Samples is reader-supported. Our editors verify every clinic here — affiliate commissions fund the work, they don't pick the winners. Full disclosure

About Peptide Samples

Peptide Samplesis an editor-ranked, reader-verified comparison directory for peptide therapies — clinical compounded peptides (sermorelin, ipamorelin, CJC-1295, GHK-Cu, thymosin alpha-1), FDA-cleared peptide drugs (tesamorelin / Egrifta, PT-141 / Vyleesi), and the educational background on every peptide that's trending (BPC-157, TB-500, and the Cat-2 long tail). We help US adults compare cost, protocol depth, lab quality, regulatory posture, and clinical fit across the 2026 peptide landscape.

We don't sell anything ourselves. When you click a link on a clinical-track page to a partner clinic and complete an intake, we may earn a commission. That commission has no influence on which providers we cover, what we say about them, or where they rank. Our editorial team is independent of every clinic we cover.

Educational-track pages (BPC-157, TB-500, etc.) carry no vendor links. Affiliate revenue cannot buy a research-chemical vendor a link on a Cat-2 peptide page. Every entry on this site is verified weekly. If a clinic changes its pricing, eligibility, or peptide formulary, we update within 24 hours. Clinics don't pay for placement and they don't see rankings before they ship.

Editorial standards

Who we are

Peptide Samples is an independent editorial publication.

Questions or corrections: hello@peptidesamples.com